Fig. 7. (A) Percentage of THP-1 cell viability treated with different concentrations (1.25–10 mg ml⁻¹) of bCuO-NPs, and (B) CLSM images of THP-1 cells treated with control doxorubicin and bCuO-NPs (*, ** denote significant differences between the treated and control).